A dedicated opportunity to connect with leaders across the COPD drug development community, bringing together experts in discovery, translational science, clinical development, and commercial strategy. Engage in focused, peer-to-peer discussions on emerging data, trial design challenges, regulatory pathways, and the future direction of COPD therapeutics.